查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566903

影像導航放射治療市場：按產品、程序和最終用戶：2024-2033 年全球機會分析和產業預測

Image-Guided Radiation Therapy Market By Product, By Procedure (IMRT, Stereotactic Therapy, Particle Therapy, Others) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

影像導航放射治療市場

2023年影像導航放射治療市場價值為19億美元，預計2024年至2033年複合年成長率為5.7%，到2033年將達到33億美元。

影像導航放射治療是癌症治療中常用的影像處理過程。這種治療方法涉及多種影像技術，包括 MRI、PET 和電腦斷層掃描，並可以精確定位放射線來殺死癌細胞。使用成像技術產生的高品質影像來實現精確瞄準。影像導引放射治療已成為現代腫瘤學實踐中必要的治療方法，因為這種方法提高了治療精度，改善了治療結果，並減少了放射相關併發症。

影像導航放射治療市場的關鍵促進因素是多種癌症盛行率的增加以及對標靶癌症治療的需求不斷增加。此外，在治療期間引入即時成像正在提高治療效果並推動對影像導航放射治療的需求。表面引導放射治療由於其最先進的特性（例如配藥內運動監測和呼吸門控）最近已在多個腫瘤中心廣泛採用。

然而，與影像導航放射治療相關的設備採購成本和患者治療成本高昂是市場的主要限制。相反，技術的進步正在使治療領域多樣化並完善治療過程。人工智慧和機器學習的融合使得能夠根據患者的生命徵象和需求提供個人化的癌症治療。例如，對於膠質母細胞瘤患者，使用基於人工智慧的劑量最佳化軟體來調整放射治療。這涉及提供最佳劑量的輻射，以最大限度地抑制腫瘤，同時保護大腦的重要部分，例如腦幹和視神經。

按部門審查

影像導航放射治療市場分為產品、程序、最終用戶和區域。依產品分為4D RT、直線加速器、MRI引導放射治療、射野成像及電腦斷層掃描。依技術分為IMRT（強度調控放射治療）、立體定位治療、粒子束治療等。依最終使用者分為醫院、獨立放射治療中心等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從產品來看，直線加速器在市場上佔據主導地位。

從手術方式來看，IMRT（強度調控放射治療）處於市場領先地位。

按地區分類，預計到 2033 年，北美地區的收益將最高。

該報告可以客製化。

  • 根據客戶興趣加入公司簡介

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章影像導引放射治療市場：依產品

  • 市場概況
  • 4D RT
  • 直線加速器
  • MRI導引放射治療
  • 門靜脈成像
  • 電腦斷層掃描

第5章影像導航放射治療市場：依程序

  • 市場概況
  • IMRT（強度調控放射治療）
  • 立體定位放射治療
  • 粒子束治療
  • 其他

第6章影像導航放射治療市場：依最終使用者分類

  • 市場概況
  • 醫院
  • 獨立放射治療中心
  • 其他

第7章影像導引放射治療市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國影像導航放射治療市場
    • 加拿大影像導航放射治療市場
    • 墨西哥影像導航放射治療市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國影像導航放射治療市場
    • 德國影像導航放射治療市場
    • 義大利影像導航放射治療市場
    • 西班牙影像導航放射治療市場
    • 英國影像導航放射治療市場
    • 其他歐洲國家影像導航放射治療市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國影像導航放射治療市場
    • 日本影像導航放射治療市場
    • 印度影像導航放射治療市場
    • 韓國影像導航放射治療市場
    • 澳洲影像導航放射治療市場
    • 其他亞太影像導航放射治療市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西影像導航放射治療市場
    • 南非影像導航放射治療市場
    • 沙烏地阿拉伯的影像導航放射治療市場
    • 其他拉丁美洲/中東/非洲影像導航放射治療市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Varian Medical Systems, Inc.
  • Elekta AB, Accuray Incorporated
  • ViewRay, Inc.
  • Siemens Healthineers AG
  • Hitachi, Ltd
  • Brainlab AG
  • MEVION MEDICAL SYSTEMS, INC.
  • C-Rad AB
  • Sumitomo Heavy Industries, Ltd.
  • Philips Healthcare
簡介目錄
Product Code: A323701

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Product

  • 4D RT
  • LINAC
  • MRI-guided Radiotherapy
  • Portal Imaging
  • CT Scanning

By Procedure

  • IMRT (intensity modulation radiation therapy)
  • Stereotactic Therapy
  • Particle Therapy
  • Others

By End User

  • Hospitals
  • Independent Radiotherapy Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Varian Medical Systems, Inc.
    • Elekta AB, Accuray Incorporated
    • ViewRay, Inc.
    • Siemens Healthineers AG
    • Hitachi, Ltd
    • Brainlab AG
    • MEVION MEDICAL SYSTEMS, INC.
    • C-Rad AB
    • Sumitomo Heavy Industries, Ltd.
    • Philips Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. 4D RT
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. LINAC
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. MRI-guided Radiotherapy
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Portal Imaging
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. CT Scanning
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Procedure
  • 5.2. IMRT (intensity Modulation Radiation Therapy)
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Stereotactic Therapy
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Particle Therapy
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Independent Radiotherapy Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Procedure
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Image-Guided Radiation Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Procedure
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Image-Guided Radiation Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Procedure
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Image-Guided Radiation Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Procedure
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Procedure
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Image-Guided Radiation Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Procedure
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Image-Guided Radiation Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Procedure
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Image-Guided Radiation Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Procedure
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Image-Guided Radiation Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Procedure
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Image-Guided Radiation Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Procedure
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Image-Guided Radiation Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Procedure
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Procedure
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Image-Guided Radiation Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Procedure
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Image-Guided Radiation Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Procedure
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Image-Guided Radiation Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Procedure
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Image-Guided Radiation Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Procedure
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Image-Guided Radiation Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Procedure
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Procedure
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Procedure
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Image-Guided Radiation Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Procedure
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Image-Guided Radiation Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Procedure
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Procedure
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Procedure
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Varian Medical Systems, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Elekta AB, Accuray Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. ViewRay, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Siemens Healthineers AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Hitachi, Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Brainlab AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. MEVION MEDICAL SYSTEMS, INC.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. C-Rad AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Sumitomo Heavy Industries, Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Philips Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments